Quantifying recruitment of cytosolic peptides for HLA class I presentation: Impact of TAP transport

Journal of Immunology

Volumn 170, Issue 6, 2003, Pages 2977-2984

  Fruci, Doriana ^a   Lauvau, Grégoire ^a   Saveanu, Loredana ^a   Amicosante, Massimo ^b   Butler, Richard H ^c   Polack, Axel ^d   Ginhoux, Florent ^e   Lemonnier, François ^e   Firat, Hüseyin ^e   Van Endert, Peter M ^a  

^a INSERM   (France)

^b NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

^c CNR   (Italy)

^d INSTITUTE OF EPIDEMIOLOGY   (Germany)

^e INSTITUT PASTEUR   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CARRIER PROTEIN; CYTOPLASM PROTEIN; EPITOPE; HLA A2 ANTIGEN; HLA ANTIGEN CLASS 1; LIGAND; PEPTIDASE; PROTEASOME; TAP PROTEIN; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ANIMAL CELL; ANTIGEN PRESENTATION; ARTICLE; BINDING AFFINITY; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; MAJOR HISTOCOMPATIBILITY COMPLEX RESTRICTION; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; PROTEIN SYNTHESIS; PROTEIN TRANSPORT;

EID: 0037443409     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.170.6.2977     Document Type: Article

References (36)

1. Pamer, E., and P. Cresswell. 1998. Mechanisms of MHC class I-restricted antigen processing. Annu. Rev. Immunol. 16:323.
2. Yewdell, J. W., and J. R. Bennink. 1999. Immunodominance in major histocompatibility complex class I-restricted T lymphocyte responses. Annu. Rev. Immunol. 17:51.
3. Rock, K. L., and A. L. Goldberg. 1999. Degradation of cell proteins and the generation of MHC class I-presented peptides. Annu. Rev. Immunol. 17:739.
4. Chen, W., L. C. Anton, J. R. Bennink, and J. W. Yewdell. 2000. Dissecting the multifactorial causes of immunodominance in class I-restricted T cell responses to viruses. Immunity 12:83.
5. Kessler, J. H., N. J. Beekman, S. A. Bres-Vloemans, P. Verdijk, P. A. van Veelen, A. M. Kloosterman-Joosten, D. C. Vissers, G. J. ten Bosch, M. G. Kester, A. Sijts, et al. 2001. Efficient identification of novel HLA-A*0201-presented cytotoxic T lymphocyte epitopes in the widely expressed tumor antigen PRAME by proteasome-mediated digestion analysis. J. Exp. Med. 193:73.
6. Niedermann, G. 2002. Immunological functions of the proteasome. Curr. Top. Microbiol. Immunol. 268:91.
7. Saric, T., J. Beninga, C. I. Graef, T. N. Akopian, K. L. Rock, and A. L. Goldberg. 2001. Major histocompatibility complex class I-presented antigenic peptides are degraded in cytosolic extracts primarily by thimet oligopeptidase. J. Biol. Chem. 276:36474.
8. van Endert, P. M. 1999. Genes regulating MHC class I processing of antigen. Curr. Opin. Immunol. 11:82.
9. Stoltze, L., M. Schirle, G. Schwarz, C. Schroeter, M. W. Thompson, L. B. Hersh, H. Kalbacher, S. Stefanovic, H.-G. Rammensee, and H. Schild. 2000. Two new proteases in the MHC class I processing pathway. Nat. Immunol. 1:413.
10. Fruci, D., G. Niedermann, R. H. Butler, and P. M. van Endert. 2001. Efficient MHC class I-independent amino-terminal trimming of epitope precursor peptides in the endoplasmic reticulum. Immunity 15:467.
11. Beninga, J., K. L. Rock, and A. L. Goldberg. 1998. Interferon-γ can stimulate post-proteasomal trimming of the N terminus of an antigenic peptide by inducing leucine aminopeptidase. J. Biol. Chem. 273:18734.
12. Serwold, T., S. Gaw, and N. Shastri. 2001. ER aminopeptidases generate a unique pool of peptides for MHC class I molecules. Nat. Immunol. 2:644.
13. Villanueva, M. S., P. Fischer, K. Feen, and E. G. Pamer. 1994. Efficiency of MHC class I antigen processing: a quantitative analysis. Immunity 1:479.
14. Yewdell, J. W. 2001. Not such a dismal science: the economics of protein synthesis, folding, degradation and antigen processing. Trends Cell Biol. 11:294.
15. Van Endert, P. M., D. Riganelli, G. Greco, K. Fleischhauer, J. Sidney, A. Sette, and J.-F. Bach. 1995. The peptide-binding motif for the human transporter associated with antigen processing. J. Exp. Med. 182:1883.
16. Powis, S. J., L. L. Young, E. Joly, P. J. Barker, L. Richardson, R. P. Brandt, C. J. Melief, J. C. Howard, and G. W. Butcher. 1996. The rat cim effect: TAP allele-dependent changes in a class I MHC anchor motif and evidence against C-terminal trimming of peptides in the ER. Immunity 4:159.
17. Yellen-Shaw, A. J., C. E. Laughlin, R. M. Metrione, and L. C. Eisenlohr. 1997. Murine transporter associated with antigen presentation (TAP) preferences influence class I-restricted T cell responses. J. Exp. Med. 186:1655.
18. Lauvau, G., K. Kakimi, G. Niedermann, M. Ostankovitch, P. Yotnda, H. Firat, F. V. Chisari, and P. M. van Endert. 1999. Human transporters associated with antigen processing (TAPs) select epitope precursor peptides for processing in the endoplasmic reticulum and presentation to T cells. J. Exp. Med. 190:1227.
19. Brickner, A. G., E. H. Warren, J. A. Caldwell, Y. Akatsuka, T. N. Golovina, A. L. Zarling, J. Shabanowitz, L. C. Eisenlohr, D. F. Hunt, V. H. Engelhard, and S. R. Riddell. 2001. The immunogenicity of a new human minor histocompatibility antigen results from differential antigen processing. J. Exp. Med. 193:195.
20. Feuillard, J., M. Schuhmacher, S. Kohanna, M. Asso-Bonnet, F. Ledeur, R. Joubert-Caron, P. Bissieres, A. Polack, G. W. Bornkamm, and M. Raphael. 2000. Inducible loss of NF-κB activity is associated with apoptosis and Bcl-2 down-regulation in Epstein-Barr virus-transformed B lymphocytes. Blood 95:2068.
21. Valmori, D., U, Gileadi, C. Servis, P. R. Dunbar, J. C. Cerottini, P. Romero, V. Cerundolo, and F. Levy. 1999. Modulation of proteasomal activity required for the generation of a cytotoxic T lymphocyte-defined peptide derived from the tumor antigen MAGE-3. J. Exp. Med. 189:895.
22. 2m double knockout mice. J. Exp. Med. 185:2043.
23. Storkus, W. J., J. Alexander, J. A. Payne, J. R. Dawson, and P. Cresswell. 1989. Reversal of natural killing susceptibility in target cells expressing transfected class I HLA genes. Proc. Natl. Acad. Sci. USA 86:2361.
24. Wang, W., S. Man, P. H. Gulden, D. F. Hunt, and V. H. Engelhard. 1998. Class I-restricted alloreactive cytotoxic T lymphocytes recognize a complex array of specific MHC-associated peptides. J. Immunol. 160:1091.
25. Bertoletti, A., F. V. Chisari, A. Penna, S. Guilhot, L. Galati, G. Missale, P. Fowler, H. J. Schlicht, A. Vitiello, R. C. Chesnut, et al. 1993. Definition of a minimal optimal cytotoxic T-cell epitope within the hepatitis B virus nucleocapsid protein. J. Virol. 67:2376.
26. Larsen, C. N., B. A. Krantz, and K. D. Wilkinson. 1998. Substrate specificity of deubiquitinating enzymes: ubiquitin C-terminal hydrolases. Biochemistry 37:3358.
27. Firat, H., F. Garcia-Pons, S. Tourdot, S. Pascolo, A. Scardino, Z. Garcia, M. L. Michel, R. W. Jack, G. Jung, K. Kosmatopoulos, et al. 1999. H-2 class I knockout, HLA-A2.1-transgenic mice: a versatile animal model for preclinical evaluation of antitumor immunotherapeutic strategies. Eur. J. Immunol. 29:3112.
28. Hershko, A., and A. Ciechanover. 1998. The ubiquitin system. Annu. Rev. Biochem. 67:425.
29. Schubert, U., L. C. Anton, J. Gibbs, C. C. Norbury, J. W. Yewdell, and J. R. Bennink. 2000. Rapid degradation of a large fraction of newly synthesized proteins by proteasomes. Nature 404:770.
30. Serwold, T., F. Gonzalez, J. Kim, R. Jacob, and N. Shastri. 2002. ERAAP customizes peptides for MHC class I molecules in the endoplasmic reticulum. Nature 419:480.
31. York, I. A., S. C. Chang, T. Saric, J. A. Keys, J. M. Favreau, A. L. Goldberg, and K. L. Rock. 2002. The ER aminopeptidase ERAP1 enhances or limits antigen presentation by trimming epitopes to 8-9 residues. Nat. Immunol. 3:1177.
32. Saric, T., S. C. Chang, A. Hattori, I. A. York, S. Markant, K. L. Rock, M. Tsujimoto, and A. L. Goldberg. 2002. An IFN-γ-induced aminopeptidase in the ER, ERAP1, trims precursors to MHC class I-presented peptides. Nat. Immunol. 3:1169.
33. Daniel, S., V. Brusic, S. Caillat-Zucman, N. Petrovsky, L. Harrison, D. Riganelli, F. Sinigaglia, F. Gallazzi, J. Hammer, and P. M. van Endert. 1998. Relationship between peptide selectivities of human transporters associated with antigen processing and HLA class I molecules. J. Immunol. 161:617.
34. Montoya, M., and M. Del Val. 1999. Intracellular rate-limiting steps in MHC class I antigen processing. J. Immunol. 163:1914.
35. Yewdell, J. W., and J. R. Bennink. 2001. Cut and trim: generating MHC class I peptide ligands. Curr. Opin. Immunol. 13:13.
36. Geier, E., G. Pfeifer, M. Wilm, M. Lucchiari-Hartz, W. Baumeister, K. Eichmann, and G. Niedermann. 1999. A giant protease with potential to substitute for some functions of the proteasome. Science 283:978.